BBP ETF
Virtus LifeSci Biotech Products ETF
BBP ETF Overview
BBP ETF (Virtus LifeSci Biotech Products ETF) is managed by Virtus Investment Partners with $133.2M in net assets. BBP expense ratio is 0.34%, holding 67 positions across sectors including Health Care. Inception date: 2014-12-16.
BBP performance shows a YTD return of 30.74%. The 1-year return is 39.68% and the 5-year return is 14.98%.
BBP top holdings include Moderna Inc (5.9%), Iovance Biotherapeutics Inc (4.5%), Verastem Inc (2.8%), Omeros Corp Com (2.5%), Halozyme Therapeutics Inc (2.4%). Go to all BBP holdings, BBP sectors, or BBP dividends.
BBP can be compared against other funds. Use BBP overlap to find shared positions, or BBP vs another fund for a side-by-side view. BBP alternatives are available via the screener, along with tax-loss harvesting opportunities.